Cargando…

Robotic selection for the rapid development of stable CHO cell lines for HIV vaccine production

The production of envelope glycoproteins (Envs) for use as HIV vaccines is challenging. The yield of Envs expressed in stable Chinese Hamster Ovary (CHO) cell lines is typically 10–100 fold lower than other glycoproteins of pharmaceutical interest. Moreover, Envs produced in CHO cells are typically...

Descripción completa

Detalles Bibliográficos
Autores principales:	O’Rourke, Sara M., Byrne, Gabriel, Tatsuno, Gwen, Wright, Meredith, Yu, Bin, Mesa, Kathryn A., Doran, Rachel C., Alexander, David, Berman, Phillip W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071959/ https://www.ncbi.nlm.nih.gov/pubmed/30071025 http://dx.doi.org/10.1371/journal.pone.0197656

Ejemplares similares

Development of a Stable MGAT1(−) CHO Cell Line to Produce Clade C gp120 With Improved Binding to Broadly Neutralizing Antibodies
por: Doran, Rachel C., et al.
Publicado: (2018)

CRISPR/Cas9 gene editing for the creation of an MGAT1-deficient CHO cell line to control HIV-1 vaccine glycosylation
por: Byrne, Gabriel, et al.
Publicado: (2018)

Gene editing in CHO cells to prevent proteolysis and enhance glycosylation: Production of HIV envelope proteins as vaccine immunogens
por: Li, Sophia W., et al.
Publicado: (2020)

Glycan modifications to the gp120 immunogens used in the RV144 vaccine trial improve binding to broadly neutralizing antibodies
por: Doran, Rachel C., et al.
Publicado: (2018)

Glycoform and Net Charge Heterogeneity in gp120 Immunogens Used in HIV Vaccine Trials
por: Yu, Bin, et al.
Publicado: (2012)

Antigen processing sites in gp120 are conserved across HIV virus clades
por: Yu, B, et al.
Publicado: (2012)

Retrovectors packaged in CHO cells to generate GLP-1-Fc stable expression CHO cell lines
por: Li, Jing, et al.
Publicado: (2019)

Characterization of a monoclonal antibody to a novel glycan-dependent epitope in the V1/V2 domain of the HIV-1 envelope protein, gp120
por: Doran, Rachel C., et al.
Publicado: (2014)

Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies
por: Chung, Nancy PY, et al.
Publicado: (2014)

Extensive glycoform heterogeneity in the gp120 envelope proteins used in the RV144 trial
por: Yu, B, et al.
Publicado: (2012)

Toolbox approach for fast generation of stable CHO production cell lines from different hosts
por: Seitz, Susanne, et al.
Publicado: (2011)

Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen
por: Nyon, Mun Peak, et al.
Publicado: (2018)

Mapping epitopes on CRF01_AE viruses recognized by broadly neutralizing antibodies in sera from elite neutralizers from North America and Thailand
por: O'Rourke, SM, et al.
Publicado: (2012)

Mutations in the V1 domain of Thai CRF01-AE viruses that confer sensitivity/resistance to broadly neutralizing antibodies
por: O'Rourke, S, et al.
Publicado: (2012)

Establishment of a stable CHO cell line with high level expression of recombinant porcine IFN-β
por: Chen, Weiye, et al.
Publicado: (2011)

Development of a CHO cell line for stable production of recombinant antibodies against human MMP9
por: Ryu, Jina, et al.
Publicado: (2022)

Glycans Flanking the Hypervariable Connecting Peptide between the A and B Strands of the V1/V2 Domain of HIV-1 gp120 Confer Resistance to Antibodies That Neutralize CRF01_AE Viruses
por: O’Rourke, Sara M., et al.
Publicado: (2015)

CHO-S Antibody Titers >1 Gram/Liter Using Flow Electroporation-Mediated Transient Gene Expression followed by Rapid Migration to High-Yield Stable Cell Lines
por: Steger, Krista, et al.
Publicado: (2015)

Engineering CHO cell growth by stable manipulation of miRNA expression
por: Sanchez, Noëlia, et al.
Publicado: (2011)

Design of a stable cell line producing a recombinant monoclonal anti-TNFα antibody based on a CHO cell line
por: Voronina, E. V., et al.
Publicado: (2016)

CHO cell lines generated by PiggyBac transposition
por: Matasci, Mattia, et al.
Publicado: (2011)

Rapid intensification of an established CHO cell fed‐batch process
por: Schulze, Markus, et al.
Publicado: (2021)

The Use of Transcription Terminators to Generate Transgenic Lines of Chinese Hamster Ovary Cells (CHO) with Stable and High Level of Reporter Gene Expression
por: Gasanov, N. B., et al.
Publicado: (2015)

Analysis of glycolytic flux as a rapid screen to identify low lactate producing CHO cell lines with desirable monoclonal antibody yield and glycan profile
por: Legmann, Rachel, et al.
Publicado: (2011)

Influence of glutamine on transient and stable recombinant protein production in CHO and HEK-293 cells
por: Rajendra, Yashas, et al.
Publicado: (2011)

Stable overexpression of miR-17 enhances recombinant protein production of CHO cells()
por: Jadhav, Vaibhav, et al.
Publicado: (2014)

Unusual Cysteine Content in V1 Region of gp120 From an Elite Suppressor That Produces Broadly Neutralizing Antibodies
por: Hutchinson, Jennie M., et al.
Publicado: (2019)

Ancestral sequences from an elite neutralizer proximal to the development of neutralization resistance as a potential source of HIV vaccine immunogens
por: Mesa, Kathryn A., et al.
Publicado: (2019)

Impact on product quality of high productive GS-CHO cell lines
por: Perani, Angelo, et al.
Publicado: (2011)

CHO starter cell lines for manufacturing of proteins with pre-defined glycoprofiles
por: Winkler, Karsten, et al.
Publicado: (2013)

Rich production media as a platform for CHO cell line development
por: Kim, Yong Jae, et al.
Publicado: (2020)

Stable Expression of Recombinant Factor VIII in CHO Cells Using Methotrexate-Driven Transgene Amplification
por: Orlova, N. A., et al.
Publicado: (2012)

Functional Trimeric SARS-CoV-2 Envelope Protein Expressed in Stable CHO Cells
por: Mayrhofer, Patrick, et al.
Publicado: (2021)

Development of a stable antibody production system utilizing an Hspa5 promoter in CHO cells
por: Tanemura, Hiroki, et al.
Publicado: (2022)

Metabolomic and quality data for early and late passages of an antibody-producing industrial CHO cell line
por: Sowa, Steven W., et al.
Publicado: (2020)

Quantitative definition and monitoring of the host cell protein proteome using iTRAQ – a study of an industrial mAb producing CHO‐S cell line
por: Chiverton, Lesley M., et al.
Publicado: (2016)

Rapid recombinant protein production from pools of transposon-generated CHO cells
por: Matasci, Mattia, et al.
Publicado: (2011)

The genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line
por: Xu, Xun, et al.
Publicado: (2011)

Characterization of recombinant IgA producing CHO cell lines by qPCR
por: Reinhart, David, et al.
Publicado: (2013)

Construction of transgene-amplified CHO cell lines by cell cycle checkpoint engineering
por: Lee, Kyoung Ho, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_k8285posnk3emn5lbjpfq2enqo